Medical Ozone for Antihyperuricemia Major Autohemotherapy using DDBD: Standard Dose Production Analysis

Khairunnisa Syahputra; Ervinawati Elyaswanto; Evita Tiara Maharani; Eko Yulianto; Siti Susanti; Sumariyah Sumariyah; Fadhilah Nur Fahada; K. Sofyan Firdausi; Muhammad Nur1

1

Publication Date: 2023/12/01

Abstract: Major autohemotherapy is a medical ozone therapy technique that is gaining increasing importance in treating several diseases. Analysis of the production of standard doses of medical ozone for antihyperuricemia in major autohemotherapy using double dielectric barrier discharge (DDBD) with a copper plate electrode configuration has been carried out. The results of the research show that the higher the applied voltage, the greater the concentration obtained for the low flow rate used. From the results above, the dose obtained is between 11.8 μg to 50.7 μg, which is the dose for therapy using the Major Autohrmotherapy method as antihyperuricemia. This dose has been tried on rabbits and the results of the treatment showed antihyperuricemia

Keywords: Medical Ozone, Double Dielectric Barrier Discharge, Major Autohemoteraphy (MAH), Hiperurisemia.

DOI: https://doi.org/10.5281/zenodo.10243164

PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT23NOV1793.pdf

REFERENCES

No References Available